Associated Papers
Pharmacogenetics of incretin-based therapies.
Yaluri AS et al.
Postgraduate Medical Journal, 2025
Integrating Pharmacogenomic Insights in GLP-1 Receptor Agonist Therapy: Direct GLP1R and ARRB1 Variants and Indirect CYP2D6 Influences in Personalized Obesity Management.
Jayathilaka NS et al.
Clinical Pharmacology in Drug Development, 2025
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.
Dawed AY et al.
The Lancet. Diabetes & Endocrinology, 2023
Select a paper to view details